Price
Target price
€0.37
€0.37
-1.070%
-0.004
-1.070%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Recce Pharmaceuticals Ltd. Stock
A loss of -1.070% shows a downward development for Recce Pharmaceuticals Ltd..
Pros and Cons of Recce Pharmaceuticals Ltd. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Recce Completes 5,000 RECCE® 327 Doses a Week under Good Manufacturing Practice (GMP)
Highlights:
- Successful production of 5,000 x RECCE® 327 (R327) doses per week under Good Manufacturing Practises (GMP) campaign.
- R327 manufactured under GMP
Recce Pharmaceuticals Selected by UK Government Innovation Agency to Participate in AMR Mission 2024
- Recce recognized by the United Kingdom Government Innovation Agency among the most promising organizations for the UK AMR Inward Mission 2024.
- Recce chosen as one of 18
Recce Pharmaceuticals (ASX:RCE, FSE:R9Q) Business Update
Highlights:
- Promising Minimum Inhibitory Concentration (MIC) activity in Phase I/II UTI/Urosepsis Trial with an increase in dosage expected to begin in the next several weeks
-